Loading clinical trials...
Loading clinical trials...
A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
No
Research Site
Jasper, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tuscon, Arizona, United States
Research Site
Buena Park, California, United States
Research Site
Huntington Beach, California, United States
Research Site
Long Beach, California, United States
Research Site
Long Beach, California, United States
Research Site
Los Angeles, California, United States
Research Site
San Diego, California, United States
Research Site
Stockton, California, United States
Start Date
March 1, 2005
Primary Completion Date
September 1, 2005
Completion Date
September 1, 2006
Last Updated
November 10, 2010
345
Estimated participants
Formoterol Fumarate
DRUG
Lead Sponsor
Dey
NCT07477600
NCT07462221
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions